TY - JOUR
T1 - Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer
AU - Chandra, Anurag
AU - Guerrero, Thomas M.
AU - Liu, H. Helen
AU - Tucker, Susan L.
AU - Liao, Zhongxing
AU - Wang, Xiaochun
AU - Murshed, Hasan
AU - Bonnen, Mark D.
AU - Garg, Amit K.
AU - Stevens, Craig W.
AU - Chang, Joe Y.
AU - Jeter, Melinda D.
AU - Mohan, Radhe
AU - Cox, James D.
AU - Komaki, Ritsuko
N1 - Funding Information:
This work was partially supported by grants NCI-CA74043 from the National Institute of Health, USA.
PY - 2005/12
Y1 - 2005/12
N2 - Background and purpose: To evaluate the feasibility whether intensity-modulated radiotherapy (IMRT) can be used to reduce doses to normal lung than three-dimensional conformal radiotherapy (3DCRT) in treating distal esophageal malignancies. Patients and methods: Ten patient cases with cancer of the distal esophagus were selected for a retrospective treatment-planning study. IMRT plans using four, seven, and nine beams (4B, 7B, and 9B) were developed for each patient and compared with the 3DCRT plan used clinically. IMRT and 3DCRT plans were evaluated with respect to PTV coverage and dose-volumes to irradiated normal structures, with statistical comparison made between the two types of plans using the Wilcoxon matched-pair signed-rank test. Results: IMRT plans (4B, 7B, 9B) reduced total lung volume treated above 10 Gy (V 10), 20 Gy (V20), mean lung dose (MLD), biological effective volume (Veff), and lung integral dose (P<0.05). The median absolute improvement with IMRT over 3DCRT was approximately 10% for V10, 5% for V20, and 2.5 Gy for MLD. IMRT improved the PTV heterogeneity (P<0.05), yet conformity was better with 7B-9B IMRT plans. No clinically meaningful differences were observed with respect to the irradiated volumes of spinal cord, heart, liver, or total body integral doses. Conclusions: Dose-volume of exposed normal lung can be reduced with IMRT, though clinical investigations are warranted to assess IMRT treatment outcome of esophagus cancers.
AB - Background and purpose: To evaluate the feasibility whether intensity-modulated radiotherapy (IMRT) can be used to reduce doses to normal lung than three-dimensional conformal radiotherapy (3DCRT) in treating distal esophageal malignancies. Patients and methods: Ten patient cases with cancer of the distal esophagus were selected for a retrospective treatment-planning study. IMRT plans using four, seven, and nine beams (4B, 7B, and 9B) were developed for each patient and compared with the 3DCRT plan used clinically. IMRT and 3DCRT plans were evaluated with respect to PTV coverage and dose-volumes to irradiated normal structures, with statistical comparison made between the two types of plans using the Wilcoxon matched-pair signed-rank test. Results: IMRT plans (4B, 7B, 9B) reduced total lung volume treated above 10 Gy (V 10), 20 Gy (V20), mean lung dose (MLD), biological effective volume (Veff), and lung integral dose (P<0.05). The median absolute improvement with IMRT over 3DCRT was approximately 10% for V10, 5% for V20, and 2.5 Gy for MLD. IMRT improved the PTV heterogeneity (P<0.05), yet conformity was better with 7B-9B IMRT plans. No clinically meaningful differences were observed with respect to the irradiated volumes of spinal cord, heart, liver, or total body integral doses. Conclusions: Dose-volume of exposed normal lung can be reduced with IMRT, though clinical investigations are warranted to assess IMRT treatment outcome of esophagus cancers.
KW - Esophageal cancer
KW - Intensity-modulated radiotherapy
KW - Three-dimensional conformal radiotherapy
KW - Treatment planning
UR - http://www.scopus.com/inward/record.url?scp=28944446823&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28944446823&partnerID=8YFLogxK
U2 - 10.1016/j.radonc.2005.10.017
DO - 10.1016/j.radonc.2005.10.017
M3 - Article
C2 - 16298001
AN - SCOPUS:28944446823
SN - 0167-8140
VL - 77
SP - 247
EP - 253
JO - Radiotherapy and Oncology
JF - Radiotherapy and Oncology
IS - 3
ER -